Actemra 200mg, a drug known scientifically as tocilizumab, is a a potent biologic agent primarily employed for the management of rheumatoid arthritis. This effective compound functions by interfering with the activity of interleukin-6 (IL-6), a signaling protein essential in the inflammatory process. Additionally, Actemra exhibits efficacy in the